AHA statement spotlights severe pediatric obesity
September 9, 2013|Type 2 Diabetes ICYMI
Author and Disclosure Information
FROM CIRCULATION
"The task ahead will be arduous and complicated, but the high prevalence and serious consequences of severe obesity require us to commit time, intellectual capital, and financial resources to address it," the writing group concluded.
Dr. Kelly disclosed that he has received research grants from Amylin Pharmaceuticals, the National Institutes of Health/National Institute of Neurological Disorders and Stroke, and the Thrasher Research Fund. He is also a consultant to Novo Nordisk. One other writing group member, Dr. Thomas H. Inge, disclosed that he has received a research grant from Ethicon Endosurgery.
To earn 0.25 hours AMA PRA Category 1 credit after reading this article, take the post-test here.
